← Back to home

BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY)

Clinical trials for BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY) explained in plain language.

Never miss a new study

Get alerted when new BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY) trials appear

Sign up with your email to follow new studies for BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Asthma Drug's Long-Term safety under the microscope

Disease control Ongoing

This study is monitoring the long-term safety of the asthma medication Tezspire in real-world use. It involves 416 patients with severe asthma that wasn't controlled by other treatments. The main goal is to track any side effects and understand what factors might affect the drug'…

Matched conditions: BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY)

Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY)

Get alerted when new BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY) trials appear

Asthma Drug's Long-Term safety under the microscope